alexa Renin-Angiotensin and Sympathetic Nervous System Interactions in the Control of Blood Pressure in Fructose-Induced Metabolic Syndrome | Open Access Journals
ISSN: 2161-0479
Journal of Autacoids and Hormones
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Renin-Angiotensin and Sympathetic Nervous System Interactions in the Control of Blood Pressure in Fructose-Induced Metabolic Syndrome

Mohammed H Abdulla1* and Edward J Johns1,2
1Department of Physiology, Western Gateway Building, University College Cork, College Road, Cork, Ireland
2Allianze University College of Medical Sciences, Wazira Medical Square, 13200 Penang, Malaysia
Corresponding Author : Mohammed H. Abdulla
Department of Physiology
Western Gateway Building
University College Cork
College Road, Cork, Ireland
E-mail: [email protected]
Received April 20, 2012; Accepted April 23, 2012; Published April 24, 2012
Citation: Abdulla MH, Johns EJ (2012) Renin -Angiotensin and Sympathetic Nervous System Interactions in the Control of Blood Pressure in Fructose-Induced Metabolic Syndrome. J Autacoids 1:e105. doi: 10.4172/2161-0479.1000e105
Copyright: © 2012 Abdulla MH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google

Visit for more related articles at Journal of Autacoids and Hormones

Editorial
Activation of the sympathetic nervous system (SNS) stimulates renin release from the juxtraglomerular cells of the kidneys that leads to the generation of angiotensin I, which is then converted to angiotensin II (Ang II), the major effector peptide of the renin-angiotensin system (RAS). The formed Ang II can facilitate noradrenaline release from the renal sympathetic nerve endings in addition to its effect in the anterior hypothalamus and rostral ventrolateral medulla (RVLM) [1,2]. At RVLM neurons, Ang II acts either postsynaptically, by decreasing K+ currents, or presynaptically by activating vasomotor sympathetic glutamatergic neurons resulting in an increase in sympathetic nerve activity and arterial blood pressure [3-5]. In the renal vasculature, Ang II enhances renal adrenergic function via a presynaptic site of action in anesthetized dogs [6], while in anaesthetised rats Ang II facilitates noradrenergic control at epithelial neuroeffector junctions [7,8]. In conscious rats, Veelken et al. have shown that endogenous Ang II modulates the sympathetic nervous impact on the kidney [9]. On the other hand, it is also recognised that chronic activation of α1- adrenoceptors can result in the down regulation of AT1 receptors [10]. Ang II has been shown to induce transcription and expression of α1- adrenoceptors, mainly α1D-subtype, in rat cultured vascular smooth muscle cells, therefore, some actions of Ang II might be mediated via genomic mechanisms [11]. This mechanism is further illustrated by the finding that the stimulatory effect of Ang II on smooth muscle cell DNA synthesis can be blunted by treatment with the α1-adrenoceptor antagonist prazosin [12]. Therefore, Villalobos-Molina and Ibarra [13] have hypothesized that a long term action of Ang II, through the stimulation of expression and function of vascular α1D-adrenoceptors, may participate in the development of hypertension.
Thus, it becomes apparent that these two major regulatory systems can interact with each other and contribute to the genesis of many disorders. This interaction has been reported in hypertensive models characterized by insulin resistance an example of which is the spontaneously hypertensive rat [14] which has been described as a model of human insulin resistance syndrome due to reduced insulinmediated glucose disposal and defective fatty acid metabolism [15,16]. A further example is the rat model of fructose-induced hypertension where the SNS and RAS both appear to play a major role [17,18], and can contribute importantly to the sustained hypertension in this model. This view is supported by the observation of increased renal sodium and fluid retention and elevated blood pressure due to hyperactivity of SNS and RAS [19-21]. Accordingly, a consensus has developed that blockade of RAS using ACE inhibitors or AT1 receptor blockers (ARB) may have beneficial effects on insulin resistance in the rat [18,22,23] and in man [24,25]. The usefulness of ACE inhibitors or ARBs involves not only improving glucose metabolism and insulin sensitivity [26] but also restores vascular function. Moreover, it has been reported that the ACE inhibitor captopril blunted the vasoconstrictor responses to the α1-adrenoceptor agonist phenylephrine [27] while the ARB losartan enhanced the vascular responsiveness in 8-week fructose-fed rats [28].
Collectively, all these reports support the notion that Ang II importantly interacts with adrenergic neurotransmission in controlling vascular tone in normal and pathophysiological states. This interaction has been clearly shown in a large number of studies [14,29,30]. Recently, reports have highlighted this interaction between AT1 receptors and α1-adrenoceptors in playing an important role in modulating vascular tone in the fructose-fed rat model [31,32]. However, neither the exact mechanism of this interaction nor its importance has been clearly identified.
 
References

































Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 11605
  • [From(publication date):
    May-2012 - Oct 23, 2017]
  • Breakdown by view type
  • HTML page views : 7814
  • PDF downloads :3791
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords